Of the 87 patients with NSCLC, 58 (66.67%) tested positive for FOXA1, and 60 (68.97%) tested positive for HER2, as depicted in Figure 5A. FOXA1 and HER2 can be expressed not only in the nucleus but also in the cytoplasm. This evidence concerns the gene FOXA1 and non-small cell lung carcinoma.